News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,324 Results
Type
Article (53927)
Company Profile (541)
Press Release (720834)
Multimedia
Podcasts (171)
Webinars (28)
Section
Business (218213)
Career Advice (2251)
Deals (37423)
Drug Delivery (125)
Drug Development (85250)
Employer Resources (196)
FDA (17481)
Job Trends (16299)
News (368836)
Policy (35855)
Tag
Academia (2936)
Academic (2)
Accelerated approval (15)
Adcomms (30)
Allergies (121)
Alliances (53353)
ALS (141)
Alzheimer's disease (1653)
Antibody-drug conjugate (ADC) (213)
Approvals (17539)
Artificial intelligence (480)
Autoimmune disease (70)
Automation (25)
Bankruptcy (377)
Best Places to Work (12559)
BIOSECURE Act (22)
Biosimilars (152)
Biotechnology (346)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (473)
Cancer (3782)
Cardiovascular disease (325)
Career advice (1890)
Career pathing (35)
CAR-T (236)
CDC (51)
Cell therapy (660)
Cervical cancer (32)
Clinical research (70850)
Collaboration (1352)
Company closure (4)
Compensation (934)
Complete response letters (51)
COVID-19 (2856)
CRISPR (79)
C-suite (582)
Cystic fibrosis (131)
Data (4343)
Decentralized trials (2)
Denatured (61)
Depression (103)
Diabetes (433)
Diagnostics (7010)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (48)
Drug discovery (225)
Drug pricing (174)
Drug shortages (34)
Duchenne muscular dystrophy (196)
Earnings (92916)
Editorial (49)
Employer branding (23)
Employer resources (163)
Events (125528)
Executive appointments (985)
FDA (19921)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1241)
Gene editing (170)
Generative AI (46)
Gene therapy (527)
GLP-1 (943)
Government (5051)
Grass and pollen (7)
Guidances (338)
Healthcare (20741)
HIV (47)
Huntington's disease (34)
IgA nephropathy (53)
Immunology and inflammation (220)
Immuno-oncology (16)
Indications (53)
Infectious disease (3077)
Inflammatory bowel disease (178)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (186)
Interviews (360)
IPO (17415)
IRA (55)
Job creations (4158)
Job search strategy (1589)
Kidney cancer (15)
Labor market (77)
Layoffs (570)
Leadership (27)
Legal (8767)
Liver cancer (89)
Longevity (12)
Lung cancer (540)
Lymphoma (261)
Machine learning (29)
Management (64)
Manufacturing (619)
MASH (135)
Medical device (14784)
Medtech (14807)
Mergers & acquisitions (20895)
Metabolic disorders (1095)
Multiple sclerosis (134)
NASH (17)
Neurodegenerative disease (214)
Neuropsychiatric disorders (56)
Neuroscience (2652)
NextGen: Class of 2025 (7390)
Non-profit (5054)
Now hiring (56)
Obesity (517)
Opinion (258)
Ovarian cancer (127)
Pain (157)
Pancreatic cancer (165)
Parkinson's disease (240)
Partnered (30)
Patents (403)
Patient recruitment (308)
Peanut (56)
People (62511)
Pharmaceutical (109)
Pharmacy benefit managers (25)
Phase I (22084)
Phase II (31089)
Phase III (23162)
Pipeline (2667)
Policy (277)
Postmarket research (2820)
Preclinical (9561)
Press Release (72)
Prostate cancer (194)
Psychedelics (49)
Radiopharmaceuticals (279)
Rare diseases (633)
Real estate (6511)
Recruiting (74)
Regulatory (25498)
Reports (65)
Research institute (2630)
Resumes & cover letters (385)
Rett syndrome (15)
RNA editing (13)
RSV (64)
Schizophrenia (130)
Series A (205)
Series B (155)
Service/supplier (26)
Sickle cell disease (77)
Special edition (24)
Spinal muscular atrophy (155)
Sponsored (37)
Startups (3958)
State (2)
Stomach cancer (15)
Supply chain (99)
Tariffs (87)
The Weekly (108)
Vaccines (978)
Venture capital (64)
Weight loss (360)
Women's health (58)
Worklife (17)
Date
Last 7 days (556)
Last 30 days (2268)
Last 365 days (33018)
2025 (25935)
2024 (37562)
2023 (42269)
2022 (53566)
2021 (58387)
2020 (57384)
2019 (50876)
2018 (38562)
2017 (34698)
2016 (34792)
2015 (40756)
2014 (34286)
2013 (29558)
2012 (31871)
2011 (32578)
2010 (31055)
Location
Africa (843)
Alabama (80)
Alaska (7)
Arizona (284)
Arkansas (14)
Asia (43382)
Australia (7186)
California (9342)
Canada (2846)
China (878)
Colorado (397)
Connecticut (416)
Delaware (255)
Europe (96830)
Florida (1383)
Georgia (314)
Hawaii (2)
Idaho (66)
Illinois (774)
India (51)
Indiana (453)
Iowa (19)
Japan (314)
Kansas (122)
Kentucky (36)
Louisiana (18)
Maine (77)
Maryland (1268)
Massachusetts (7025)
Michigan (312)
Minnesota (559)
Mississippi (4)
Missouri (118)
Montana (32)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2597)
New Mexico (32)
New York (2553)
North Carolina (1374)
North Dakota (10)
Northern California (4232)
Ohio (295)
Oklahoma (22)
Oregon (44)
Pennsylvania (1952)
Puerto Rico (19)
Rhode Island (46)
South America (1258)
South Carolina (49)
South Dakota (1)
Southern California (3592)
Tennessee (149)
Texas (1454)
United States (34506)
Utah (280)
Virginia (242)
Washington D.C. (81)
Washington State (797)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
775,324 Results for "ht medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History
September 17, 2025
·
6 min read
Press Releases
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities
September 25, 2025
·
6 min read
Press Releases
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
October 10, 2025
·
7 min read
Press Releases
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
October 7, 2025
·
1 min read
Press Releases
Hoth Therapeutics’ Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
September 3, 2025
·
5 min read
Press Releases
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe
July 30, 2025
·
4 min read
Press Releases
Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
September 11, 2025
·
4 min read
Press Releases
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
August 26, 2025
·
6 min read
Press Releases
Hoth Therapeutics to host KOL Event Spotlighting HT-001, Novel Therapy
June 23, 2025
·
4 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
August 21, 2025
·
1 min read
1 of 77,533
Next
